nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Estradiol—osteoporosis	0.367	1	CbGbCtD
Raltegravir—CCR1—GPCR ligand binding—PTH1R—osteoporosis	0.00236	0.0463	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CALCR—osteoporosis	0.00236	0.0463	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CNR2—osteoporosis	0.00199	0.0392	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00185	0.0363	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00159	0.0311	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PTH1R—osteoporosis	0.00133	0.0262	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CALCR—osteoporosis	0.00133	0.0262	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—PTH—osteoporosis	0.00124	0.0243	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PTH1R—osteoporosis	0.00121	0.0238	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CALCR—osteoporosis	0.00121	0.0238	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CNR2—osteoporosis	0.00121	0.0237	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—WNT1—osteoporosis	0.00114	0.0223	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—ADCY5—osteoporosis	0.00106	0.0209	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—MGLL—osteoporosis	0.00106	0.0208	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—PTHLH—osteoporosis	0.00103	0.0202	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—MGLL—osteoporosis	0.000962	0.0189	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—POMC—osteoporosis	0.000926	0.0182	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CALCA—osteoporosis	0.000904	0.0178	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SOST—osteoporosis	0.000791	0.0155	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—POMC—osteoporosis	0.000781	0.0153	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTH1R—osteoporosis	0.000715	0.014	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CALCR—osteoporosis	0.000715	0.014	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PTH—osteoporosis	0.0007	0.0138	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CNR2—osteoporosis	0.000683	0.0134	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP27A1—osteoporosis	0.000662	0.013	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000653	0.0128	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PTH—osteoporosis	0.000636	0.0125	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000621	0.0122	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CNR2—osteoporosis	0.00062	0.0122	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—WNT1—osteoporosis	0.000583	0.0114	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PTHLH—osteoporosis	0.00058	0.0114	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MGLL—osteoporosis	0.000568	0.0112	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LRP5—osteoporosis	0.000555	0.0109	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LRP6—osteoporosis	0.000531	0.0104	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PTHLH—osteoporosis	0.000527	0.0103	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CALCA—osteoporosis	0.000511	0.01	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—POMC—osteoporosis	0.000473	0.00929	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CALCA—osteoporosis	0.000464	0.00911	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TLN1—osteoporosis	0.000448	0.00879	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000446	0.00875	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—P4HB—osteoporosis	0.000386	0.00758	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTH—osteoporosis	0.000376	0.00738	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—RAP1A—osteoporosis	0.000369	0.00725	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CNR2—osteoporosis	0.000366	0.00719	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—ADCY5—osteoporosis	0.000363	0.00714	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NFATC1—osteoporosis	0.00036	0.00707	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—DKK1—osteoporosis	0.000357	0.00702	CbGpPWpGaD
Raltegravir—Dermatitis—Etidronic acid—osteoporosis	0.000351	0.000603	CcSEcCtD
Raltegravir—Vertigo—Conjugated Estrogens—osteoporosis	0.000351	0.000603	CcSEcCtD
Raltegravir—Hyperhidrosis—Pamidronate—osteoporosis	0.00035	0.000602	CcSEcCtD
Raltegravir—Hypertension—Zoledronate—osteoporosis	0.00035	0.000601	CcSEcCtD
Raltegravir—Hypersensitivity—Alendronate—osteoporosis	0.00035	0.000601	CcSEcCtD
Raltegravir—Headache—Etidronic acid—osteoporosis	0.000349	0.0006	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—CYP19A1—osteoporosis	0.000348	0.00683	CbGpPWpGaD
Raltegravir—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000347	0.000597	CcSEcCtD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000346	0.0068	CbGpPWpGaD
Raltegravir—Asthenia—Estropipate—osteoporosis	0.000346	0.000594	CcSEcCtD
Raltegravir—Visual impairment—Estradiol—osteoporosis	0.000346	0.000594	CcSEcCtD
Raltegravir—Myalgia—Zoledronate—osteoporosis	0.000345	0.000593	CcSEcCtD
Raltegravir—Arthralgia—Zoledronate—osteoporosis	0.000345	0.000593	CcSEcCtD
Raltegravir—Chest pain—Zoledronate—osteoporosis	0.000345	0.000593	CcSEcCtD
Raltegravir—Palpitations—Conjugated Estrogens—osteoporosis	0.000345	0.000593	CcSEcCtD
Raltegravir—Insomnia—Risedronate—osteoporosis	0.000345	0.000592	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—WNT1—osteoporosis	0.000344	0.00676	CbGpPWpGaD
Raltegravir—Anxiety—Zoledronate—osteoporosis	0.000344	0.000591	CcSEcCtD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000343	0.00674	CbGpPWpGaD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000343	0.000589	CcSEcCtD
Raltegravir—Paraesthesia—Risedronate—osteoporosis	0.000342	0.000588	CcSEcCtD
Raltegravir—Pruritus—Estropipate—osteoporosis	0.000341	0.000586	CcSEcCtD
Raltegravir—Discomfort—Zoledronate—osteoporosis	0.000341	0.000586	CcSEcCtD
Raltegravir—Asthenia—Alendronate—osteoporosis	0.000341	0.000585	CcSEcCtD
Raltegravir—Hypersensitivity—Ibandronate—osteoporosis	0.000341	0.000585	CcSEcCtD
Raltegravir—Cough—Conjugated Estrogens—osteoporosis	0.000341	0.000585	CcSEcCtD
Raltegravir—Erythema multiforme—Estradiol—osteoporosis	0.000339	0.000583	CcSEcCtD
Raltegravir—Dry mouth—Zoledronate—osteoporosis	0.000338	0.00058	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000338	0.00058	CcSEcCtD
Raltegravir—Fatigue—Ethinyl Estradiol—osteoporosis	0.000337	0.000579	CcSEcCtD
Raltegravir—Pruritus—Alendronate—osteoporosis	0.000336	0.000577	CcSEcCtD
Raltegravir—Dyspepsia—Risedronate—osteoporosis	0.000336	0.000576	CcSEcCtD
Raltegravir—Eye disorder—Estradiol—osteoporosis	0.000335	0.000576	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—FGA—osteoporosis	0.000335	0.00657	CbGpPWpGaD
Raltegravir—Tinnitus—Estradiol—osteoporosis	0.000335	0.000575	CcSEcCtD
Raltegravir—Constipation—Ethinyl Estradiol—osteoporosis	0.000334	0.000574	CcSEcCtD
Raltegravir—Confusional state—Zoledronate—osteoporosis	0.000334	0.000573	CcSEcCtD
Raltegravir—Hypersensitivity—Calcitriol—osteoporosis	0.000334	0.000573	CcSEcCtD
Raltegravir—Cardiac disorder—Estradiol—osteoporosis	0.000333	0.000572	CcSEcCtD
Raltegravir—Myalgia—Conjugated Estrogens—osteoporosis	0.000332	0.000571	CcSEcCtD
Raltegravir—Chest pain—Conjugated Estrogens—osteoporosis	0.000332	0.000571	CcSEcCtD
Raltegravir—Arthralgia—Conjugated Estrogens—osteoporosis	0.000332	0.000571	CcSEcCtD
Raltegravir—Asthenia—Ibandronate—osteoporosis	0.000332	0.00057	CcSEcCtD
Raltegravir—Anxiety—Conjugated Estrogens—osteoporosis	0.000331	0.000569	CcSEcCtD
Raltegravir—Nausea—Etidronic acid—osteoporosis	0.000331	0.000569	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00033	0.000567	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00033	0.000567	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—ADCY5—osteoporosis	0.00033	0.00648	CbGpPWpGaD
Raltegravir—Diarrhoea—Estropipate—osteoporosis	0.00033	0.000567	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Risedronate—osteoporosis	0.000329	0.000565	CcSEcCtD
Raltegravir—Infection—Zoledronate—osteoporosis	0.000329	0.000565	CcSEcCtD
Raltegravir—Fatigue—Risedronate—osteoporosis	0.000329	0.000564	CcSEcCtD
Raltegravir—Insomnia—Pamidronate—osteoporosis	0.000328	0.000563	CcSEcCtD
Raltegravir—Pruritus—Ibandronate—osteoporosis	0.000327	0.000562	CcSEcCtD
Raltegravir—Constipation—Risedronate—osteoporosis	0.000326	0.00056	CcSEcCtD
Raltegravir—Pain—Risedronate—osteoporosis	0.000326	0.00056	CcSEcCtD
Raltegravir—Angiopathy—Estradiol—osteoporosis	0.000326	0.000559	CcSEcCtD
Raltegravir—Paraesthesia—Pamidronate—osteoporosis	0.000325	0.000559	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—AGER—osteoporosis	0.000325	0.00638	CbGpPWpGaD
Raltegravir—Diarrhoea—Alendronate—osteoporosis	0.000325	0.000558	CcSEcCtD
Raltegravir—Asthenia—Calcitriol—osteoporosis	0.000325	0.000558	CcSEcCtD
Raltegravir—Nervous system disorder—Zoledronate—osteoporosis	0.000325	0.000558	CcSEcCtD
Raltegravir—Immune system disorder—Estradiol—osteoporosis	0.000324	0.000557	CcSEcCtD
Raltegravir—Thrombocytopenia—Zoledronate—osteoporosis	0.000324	0.000557	CcSEcCtD
Raltegravir—Mediastinal disorder—Estradiol—osteoporosis	0.000324	0.000556	CcSEcCtD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000323	0.00635	CbGpPWpGaD
Raltegravir—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000322	0.000553	CcSEcCtD
Raltegravir—Chills—Estradiol—osteoporosis	0.000322	0.000553	CcSEcCtD
Raltegravir—Somnolence—Pamidronate—osteoporosis	0.000322	0.000553	CcSEcCtD
Raltegravir—Skin disorder—Zoledronate—osteoporosis	0.000321	0.000552	CcSEcCtD
Raltegravir—Pruritus—Calcitriol—osteoporosis	0.00032	0.00055	CcSEcCtD
Raltegravir—Hyperhidrosis—Zoledronate—osteoporosis	0.00032	0.00055	CcSEcCtD
Raltegravir—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00032	0.000549	CcSEcCtD
Raltegravir—Diarrhoea—Raloxifene—osteoporosis	0.00032	0.000549	CcSEcCtD
Raltegravir—Dyspepsia—Pamidronate—osteoporosis	0.000319	0.000548	CcSEcCtD
Raltegravir—Dizziness—Estropipate—osteoporosis	0.000319	0.000548	CcSEcCtD
Raltegravir—Alopecia—Estradiol—osteoporosis	0.000317	0.000545	CcSEcCtD
Raltegravir—Infection—Conjugated Estrogens—osteoporosis	0.000317	0.000544	CcSEcCtD
Raltegravir—Diarrhoea—Ibandronate—osteoporosis	0.000316	0.000544	CcSEcCtD
Raltegravir—Decreased appetite—Pamidronate—osteoporosis	0.000315	0.000541	CcSEcCtD
Raltegravir—Mental disorder—Estradiol—osteoporosis	0.000315	0.00054	CcSEcCtD
Raltegravir—Dizziness—Alendronate—osteoporosis	0.000314	0.00054	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000313	0.000537	CcSEcCtD
Raltegravir—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000313	0.000537	CcSEcCtD
Raltegravir—Malnutrition—Estradiol—osteoporosis	0.000313	0.000537	CcSEcCtD
Raltegravir—Erythema—Estradiol—osteoporosis	0.000313	0.000537	CcSEcCtD
Raltegravir—Fatigue—Pamidronate—osteoporosis	0.000312	0.000537	CcSEcCtD
Raltegravir—Gastrointestinal pain—Risedronate—osteoporosis	0.000312	0.000535	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PTHLH—osteoporosis	0.000311	0.00611	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—BMP2—osteoporosis	0.000311	0.00611	CbGpPWpGaD
Raltegravir—Urticaria—Ethinyl Estradiol—osteoporosis	0.000311	0.000533	CcSEcCtD
Raltegravir—Constipation—Pamidronate—osteoporosis	0.00031	0.000532	CcSEcCtD
Raltegravir—Pain—Pamidronate—osteoporosis	0.00031	0.000532	CcSEcCtD
Raltegravir—Diarrhoea—Calcitriol—osteoporosis	0.00031	0.000532	CcSEcCtD
Raltegravir—Skin disorder—Conjugated Estrogens—osteoporosis	0.00031	0.000532	CcSEcCtD
Raltegravir—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000309	0.000531	CcSEcCtD
Raltegravir—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000309	0.000531	CcSEcCtD
Raltegravir—Dizziness—Raloxifene—osteoporosis	0.000309	0.000531	CcSEcCtD
Raltegravir—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000308	0.000529	CcSEcCtD
Raltegravir—Flatulence—Estradiol—osteoporosis	0.000308	0.000529	CcSEcCtD
Raltegravir—Vomiting—Estropipate—osteoporosis	0.000307	0.000527	CcSEcCtD
Raltegravir—Dysgeusia—Estradiol—osteoporosis	0.000306	0.000526	CcSEcCtD
Raltegravir—Dizziness—Ibandronate—osteoporosis	0.000306	0.000525	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—FGB—osteoporosis	0.000305	0.00598	CbGpPWpGaD
Raltegravir—Rash—Estropipate—osteoporosis	0.000304	0.000522	CcSEcCtD
Raltegravir—Dermatitis—Estropipate—osteoporosis	0.000304	0.000522	CcSEcCtD
Raltegravir—Nervousness—Estradiol—osteoporosis	0.000304	0.000521	CcSEcCtD
Raltegravir—Urticaria—Risedronate—osteoporosis	0.000303	0.00052	CcSEcCtD
Raltegravir—Back pain—Estradiol—osteoporosis	0.000302	0.000519	CcSEcCtD
Raltegravir—Headache—Estropipate—osteoporosis	0.000302	0.000519	CcSEcCtD
Raltegravir—Vomiting—Alendronate—osteoporosis	0.000302	0.000519	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000302	0.000518	CcSEcCtD
Raltegravir—Body temperature increased—Risedronate—osteoporosis	0.000301	0.000518	CcSEcCtD
Raltegravir—Abdominal pain—Risedronate—osteoporosis	0.000301	0.000518	CcSEcCtD
Raltegravir—Rash—Alendronate—osteoporosis	0.0003	0.000514	CcSEcCtD
Raltegravir—Insomnia—Zoledronate—osteoporosis	0.000299	0.000514	CcSEcCtD
Raltegravir—Dermatitis—Alendronate—osteoporosis	0.000299	0.000514	CcSEcCtD
Raltegravir—Feeling abnormal—Pamidronate—osteoporosis	0.000299	0.000513	CcSEcCtD
Raltegravir—Headache—Alendronate—osteoporosis	0.000298	0.000511	CcSEcCtD
Raltegravir—Paraesthesia—Zoledronate—osteoporosis	0.000297	0.00051	CcSEcCtD
Raltegravir—Vomiting—Raloxifene—osteoporosis	0.000297	0.00051	CcSEcCtD
Raltegravir—Gastrointestinal pain—Pamidronate—osteoporosis	0.000296	0.000509	CcSEcCtD
Raltegravir—Rash—Raloxifene—osteoporosis	0.000295	0.000506	CcSEcCtD
Raltegravir—Dermatitis—Raloxifene—osteoporosis	0.000294	0.000506	CcSEcCtD
Raltegravir—Somnolence—Zoledronate—osteoporosis	0.000294	0.000505	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PSMA5—osteoporosis	0.000294	0.00577	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PSMA2—osteoporosis	0.000294	0.00577	CbGpPWpGaD
Raltegravir—Vomiting—Ibandronate—osteoporosis	0.000294	0.000505	CcSEcCtD
Raltegravir—Tremor—Estradiol—osteoporosis	0.000293	0.000503	CcSEcCtD
Raltegravir—Headache—Raloxifene—osteoporosis	0.000293	0.000503	CcSEcCtD
Raltegravir—Rash—Ibandronate—osteoporosis	0.000292	0.000501	CcSEcCtD
Raltegravir—Dermatitis—Ibandronate—osteoporosis	0.000291	0.0005	CcSEcCtD
Raltegravir—Dyspepsia—Zoledronate—osteoporosis	0.000291	0.0005	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00029	0.000499	CcSEcCtD
Raltegravir—Ill-defined disorder—Estradiol—osteoporosis	0.00029	0.000498	CcSEcCtD
Raltegravir—Headache—Ibandronate—osteoporosis	0.00029	0.000498	CcSEcCtD
Raltegravir—Insomnia—Conjugated Estrogens—osteoporosis	0.000288	0.000495	CcSEcCtD
Raltegravir—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000288	0.000495	CcSEcCtD
Raltegravir—Vomiting—Calcitriol—osteoporosis	0.000288	0.000494	CcSEcCtD
Raltegravir—Decreased appetite—Zoledronate—osteoporosis	0.000288	0.000494	CcSEcCtD
Raltegravir—Agitation—Estradiol—osteoporosis	0.000287	0.000493	CcSEcCtD
Raltegravir—Nausea—Estropipate—osteoporosis	0.000286	0.000492	CcSEcCtD
Raltegravir—Abdominal pain—Pamidronate—osteoporosis	0.000286	0.000492	CcSEcCtD
Raltegravir—Body temperature increased—Pamidronate—osteoporosis	0.000286	0.000492	CcSEcCtD
Raltegravir—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000286	0.000492	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000286	0.000491	CcSEcCtD
Raltegravir—Rash—Calcitriol—osteoporosis	0.000285	0.00049	CcSEcCtD
Raltegravir—Fatigue—Zoledronate—osteoporosis	0.000285	0.00049	CcSEcCtD
Raltegravir—Dermatitis—Calcitriol—osteoporosis	0.000285	0.00049	CcSEcCtD
Raltegravir—Headache—Calcitriol—osteoporosis	0.000284	0.000487	CcSEcCtD
Raltegravir—Somnolence—Conjugated Estrogens—osteoporosis	0.000283	0.000487	CcSEcCtD
Raltegravir—Pain—Zoledronate—osteoporosis	0.000283	0.000486	CcSEcCtD
Raltegravir—Constipation—Zoledronate—osteoporosis	0.000283	0.000486	CcSEcCtD
Raltegravir—Nausea—Alendronate—osteoporosis	0.000282	0.000485	CcSEcCtD
Raltegravir—Malaise—Estradiol—osteoporosis	0.000282	0.000484	CcSEcCtD
Raltegravir—Hypersensitivity—Risedronate—osteoporosis	0.000281	0.000482	CcSEcCtD
Raltegravir—Vertigo—Estradiol—osteoporosis	0.000281	0.000482	CcSEcCtD
Raltegravir—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000281	0.000482	CcSEcCtD
Raltegravir—Asthenia—Ethinyl Estradiol—osteoporosis	0.00028	0.000482	CcSEcCtD
Raltegravir—Nausea—Raloxifene—osteoporosis	0.000277	0.000477	CcSEcCtD
Raltegravir—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000277	0.000476	CcSEcCtD
Raltegravir—Pruritus—Ethinyl Estradiol—osteoporosis	0.000277	0.000475	CcSEcCtD
Raltegravir—Palpitations—Estradiol—osteoporosis	0.000276	0.000474	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000275	0.000473	CcSEcCtD
Raltegravir—Fatigue—Conjugated Estrogens—osteoporosis	0.000275	0.000472	CcSEcCtD
Raltegravir—Nausea—Ibandronate—osteoporosis	0.000275	0.000472	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CALCA—osteoporosis	0.000274	0.00538	CbGpPWpGaD
Raltegravir—Asthenia—Risedronate—osteoporosis	0.000273	0.00047	CcSEcCtD
Raltegravir—Feeling abnormal—Zoledronate—osteoporosis	0.000273	0.000468	CcSEcCtD
Raltegravir—Cough—Estradiol—osteoporosis	0.000273	0.000468	CcSEcCtD
Raltegravir—Pain—Conjugated Estrogens—osteoporosis	0.000273	0.000468	CcSEcCtD
Raltegravir—Constipation—Conjugated Estrogens—osteoporosis	0.000273	0.000468	CcSEcCtD
Raltegravir—Gastrointestinal pain—Zoledronate—osteoporosis	0.000271	0.000465	CcSEcCtD
Raltegravir—Hypertension—Estradiol—osteoporosis	0.00027	0.000463	CcSEcCtD
Raltegravir—Pruritus—Risedronate—osteoporosis	0.00027	0.000463	CcSEcCtD
Raltegravir—Nausea—Calcitriol—osteoporosis	0.000269	0.000462	CcSEcCtD
Raltegravir—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000267	0.000459	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—POMC—osteoporosis	0.000267	0.00525	CbGpPWpGaD
Raltegravir—Hypersensitivity—Pamidronate—osteoporosis	0.000267	0.000459	CcSEcCtD
Raltegravir—Myalgia—Estradiol—osteoporosis	0.000266	0.000457	CcSEcCtD
Raltegravir—Chest pain—Estradiol—osteoporosis	0.000266	0.000457	CcSEcCtD
Raltegravir—Arthralgia—Estradiol—osteoporosis	0.000266	0.000457	CcSEcCtD
Raltegravir—Anxiety—Estradiol—osteoporosis	0.000265	0.000455	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000264	0.000454	CcSEcCtD
Raltegravir—Urticaria—Zoledronate—osteoporosis	0.000263	0.000452	CcSEcCtD
Raltegravir—Discomfort—Estradiol—osteoporosis	0.000263	0.000452	CcSEcCtD
Raltegravir—Abdominal pain—Zoledronate—osteoporosis	0.000262	0.000449	CcSEcCtD
Raltegravir—Body temperature increased—Zoledronate—osteoporosis	0.000262	0.000449	CcSEcCtD
Raltegravir—Diarrhoea—Risedronate—osteoporosis	0.000261	0.000448	CcSEcCtD
Raltegravir—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000261	0.000448	CcSEcCtD
Raltegravir—Dry mouth—Estradiol—osteoporosis	0.00026	0.000447	CcSEcCtD
Raltegravir—Asthenia—Pamidronate—osteoporosis	0.00026	0.000447	CcSEcCtD
Raltegravir—Dizziness—Ethinyl Estradiol—osteoporosis	0.000259	0.000444	CcSEcCtD
Raltegravir—Confusional state—Estradiol—osteoporosis	0.000257	0.000442	CcSEcCtD
Raltegravir—Pruritus—Pamidronate—osteoporosis	0.000256	0.00044	CcSEcCtD
Raltegravir—Infection—Estradiol—osteoporosis	0.000253	0.000435	CcSEcCtD
Raltegravir—Urticaria—Conjugated Estrogens—osteoporosis	0.000253	0.000435	CcSEcCtD
Raltegravir—Dizziness—Risedronate—osteoporosis	0.000252	0.000433	CcSEcCtD
Raltegravir—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000252	0.000433	CcSEcCtD
Raltegravir—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000252	0.000433	CcSEcCtD
Raltegravir—Nervous system disorder—Estradiol—osteoporosis	0.00025	0.00043	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—KL—osteoporosis	0.000249	0.00489	CbGpPWpGaD
Raltegravir—Vomiting—Ethinyl Estradiol—osteoporosis	0.000249	0.000427	CcSEcCtD
Raltegravir—Diarrhoea—Pamidronate—osteoporosis	0.000248	0.000426	CcSEcCtD
Raltegravir—Skin disorder—Estradiol—osteoporosis	0.000248	0.000426	CcSEcCtD
Raltegravir—Hyperhidrosis—Estradiol—osteoporosis	0.000247	0.000424	CcSEcCtD
Raltegravir—Rash—Ethinyl Estradiol—osteoporosis	0.000246	0.000423	CcSEcCtD
Raltegravir—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000246	0.000423	CcSEcCtD
Raltegravir—Headache—Ethinyl Estradiol—osteoporosis	0.000245	0.000421	CcSEcCtD
Raltegravir—Hypersensitivity—Zoledronate—osteoporosis	0.000244	0.000419	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—POMC—osteoporosis	0.000243	0.00477	CbGpPWpGaD
Raltegravir—Vomiting—Risedronate—osteoporosis	0.000242	0.000416	CcSEcCtD
Raltegravir—Rash—Risedronate—osteoporosis	0.00024	0.000413	CcSEcCtD
Raltegravir—Dermatitis—Risedronate—osteoporosis	0.00024	0.000412	CcSEcCtD
Raltegravir—Dizziness—Pamidronate—osteoporosis	0.00024	0.000412	CcSEcCtD
Raltegravir—Headache—Risedronate—osteoporosis	0.000239	0.00041	CcSEcCtD
Raltegravir—Asthenia—Zoledronate—osteoporosis	0.000237	0.000408	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—IL6R—osteoporosis	0.000237	0.00465	CbGpPWpGaD
Raltegravir—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000235	0.000403	CcSEcCtD
Raltegravir—Pruritus—Zoledronate—osteoporosis	0.000234	0.000402	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000232	0.000399	CcSEcCtD
Raltegravir—Nausea—Ethinyl Estradiol—osteoporosis	0.000232	0.000399	CcSEcCtD
Raltegravir—Insomnia—Estradiol—osteoporosis	0.000231	0.000396	CcSEcCtD
Raltegravir—Vomiting—Pamidronate—osteoporosis	0.00023	0.000396	CcSEcCtD
Raltegravir—Paraesthesia—Estradiol—osteoporosis	0.000229	0.000393	CcSEcCtD
Raltegravir—Asthenia—Conjugated Estrogens—osteoporosis	0.000229	0.000393	CcSEcCtD
Raltegravir—Rash—Pamidronate—osteoporosis	0.000228	0.000392	CcSEcCtD
Raltegravir—Dermatitis—Pamidronate—osteoporosis	0.000228	0.000392	CcSEcCtD
Raltegravir—Headache—Pamidronate—osteoporosis	0.000227	0.00039	CcSEcCtD
Raltegravir—Somnolence—Estradiol—osteoporosis	0.000227	0.000389	CcSEcCtD
Raltegravir—Diarrhoea—Zoledronate—osteoporosis	0.000226	0.000389	CcSEcCtD
Raltegravir—Nausea—Risedronate—osteoporosis	0.000226	0.000389	CcSEcCtD
Raltegravir—Pruritus—Conjugated Estrogens—osteoporosis	0.000225	0.000387	CcSEcCtD
Raltegravir—Dyspepsia—Estradiol—osteoporosis	0.000225	0.000386	CcSEcCtD
Raltegravir—Decreased appetite—Estradiol—osteoporosis	0.000222	0.000381	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Estradiol—osteoporosis	0.00022	0.000378	CcSEcCtD
Raltegravir—Fatigue—Estradiol—osteoporosis	0.00022	0.000378	CcSEcCtD
Raltegravir—Dizziness—Zoledronate—osteoporosis	0.000219	0.000376	CcSEcCtD
Raltegravir—Pain—Estradiol—osteoporosis	0.000218	0.000375	CcSEcCtD
Raltegravir—Constipation—Estradiol—osteoporosis	0.000218	0.000375	CcSEcCtD
Raltegravir—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000218	0.000375	CcSEcCtD
Raltegravir—Nausea—Pamidronate—osteoporosis	0.000215	0.00037	CcSEcCtD
Raltegravir—Dizziness—Conjugated Estrogens—osteoporosis	0.000211	0.000362	CcSEcCtD
Raltegravir—Vomiting—Zoledronate—osteoporosis	0.00021	0.000361	CcSEcCtD
Raltegravir—Feeling abnormal—Estradiol—osteoporosis	0.00021	0.000361	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—POMC—osteoporosis	0.000209	0.0041	CbGpPWpGaD
Raltegravir—Rash—Zoledronate—osteoporosis	0.000209	0.000358	CcSEcCtD
Raltegravir—Gastrointestinal pain—Estradiol—osteoporosis	0.000209	0.000358	CcSEcCtD
Raltegravir—Dermatitis—Zoledronate—osteoporosis	0.000208	0.000358	CcSEcCtD
Raltegravir—Headache—Zoledronate—osteoporosis	0.000207	0.000356	CcSEcCtD
Raltegravir—Vomiting—Conjugated Estrogens—osteoporosis	0.000203	0.000348	CcSEcCtD
Raltegravir—Urticaria—Estradiol—osteoporosis	0.000203	0.000348	CcSEcCtD
Raltegravir—Abdominal pain—Estradiol—osteoporosis	0.000202	0.000346	CcSEcCtD
Raltegravir—Body temperature increased—Estradiol—osteoporosis	0.000202	0.000346	CcSEcCtD
Raltegravir—Rash—Conjugated Estrogens—osteoporosis	0.000201	0.000345	CcSEcCtD
Raltegravir—Dermatitis—Conjugated Estrogens—osteoporosis	0.000201	0.000345	CcSEcCtD
Raltegravir—Headache—Conjugated Estrogens—osteoporosis	0.0002	0.000343	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—FDPS—osteoporosis	0.000197	0.00387	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PKM—osteoporosis	0.000197	0.00387	CbGpPWpGaD
Raltegravir—Nausea—Zoledronate—osteoporosis	0.000197	0.000338	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—ADCY5—osteoporosis	0.000195	0.00383	CbGpPWpGaD
Raltegravir—Nausea—Conjugated Estrogens—osteoporosis	0.000189	0.000325	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—SPP1—osteoporosis	0.000189	0.0037	CbGpPWpGaD
Raltegravir—Hypersensitivity—Estradiol—osteoporosis	0.000188	0.000323	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—GPD2—osteoporosis	0.000187	0.00367	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PGLS—osteoporosis	0.000187	0.00367	CbGpPWpGaD
Raltegravir—Asthenia—Estradiol—osteoporosis	0.000183	0.000314	CcSEcCtD
Raltegravir—Pruritus—Estradiol—osteoporosis	0.00018	0.00031	CcSEcCtD
Raltegravir—Diarrhoea—Estradiol—osteoporosis	0.000175	0.0003	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—PNP—osteoporosis	0.000171	0.00336	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ATIC—osteoporosis	0.000171	0.00336	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IRS2—osteoporosis	0.000171	0.00335	CbGpPWpGaD
Raltegravir—Dizziness—Estradiol—osteoporosis	0.000169	0.00029	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—LEP—osteoporosis	0.000167	0.00328	CbGpPWpGaD
Raltegravir—Vomiting—Estradiol—osteoporosis	0.000162	0.000279	CcSEcCtD
Raltegravir—Rash—Estradiol—osteoporosis	0.000161	0.000276	CcSEcCtD
Raltegravir—Dermatitis—Estradiol—osteoporosis	0.000161	0.000276	CcSEcCtD
Raltegravir—Headache—Estradiol—osteoporosis	0.00016	0.000274	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—ESR1—osteoporosis	0.000159	0.00313	CbGpPWpGaD
Raltegravir—Nausea—Estradiol—osteoporosis	0.000151	0.00026	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IRS1—osteoporosis	0.000149	0.00292	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CA2—osteoporosis	0.000145	0.00285	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—OXCT1—osteoporosis	0.000145	0.00285	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—POMC—osteoporosis	0.000143	0.00282	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MGLL—osteoporosis	0.000142	0.00278	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6R—osteoporosis	0.00014	0.00275	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IGF1—osteoporosis	0.000138	0.00271	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—TGFB1—osteoporosis	0.000137	0.0027	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—IDH2—osteoporosis	0.00012	0.00236	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP27A1—osteoporosis	0.000113	0.00222	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ACP5—osteoporosis	0.00011	0.00216	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6—osteoporosis	0.000105	0.00207	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—TPI1—osteoporosis	0.000102	0.00201	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—P4HB—osteoporosis	9.63e-05	0.00189	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GAPDH—osteoporosis	9.45e-05	0.00186	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—RAP1A—osteoporosis	9.21e-05	0.00181	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MYC—osteoporosis	8.29e-05	0.00163	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TGFB1—osteoporosis	8.27e-05	0.00162	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ENO1—osteoporosis	7.44e-05	0.00146	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PSMA2—osteoporosis	7.33e-05	0.00144	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PSMA5—osteoporosis	7.33e-05	0.00144	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6—osteoporosis	6.23e-05	0.00122	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP19A1—osteoporosis	5.95e-05	0.00117	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ADCY5—osteoporosis	4.86e-05	0.000954	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GPX1—osteoporosis	4.84e-05	0.000951	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MTHFR—osteoporosis	4.47e-05	0.000878	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—POMC—osteoporosis	3.58e-05	0.000702	CbGpPWpGaD
